Interestingly, while IL-24 expression did not correlate with overall survival in melanoma patients (Fig. S9C), it was associated with improved survival outcomes in patients treated with anti-PD-1 therapy (Fig. S9D). This evidence concerns the gene IL24 and melanoma.